Featured Article

Merk announced today that its first-in-class drug, sotatercept-csrk (Winrevair), for the treatment of pulmonary arterial hypertension (PAH) has been approved by the U.S. FDA.

Precision Oncology Today

Magazine

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

Already a popular topic, the launch of the large language model-based chatbot, ChatGPT, at the end of 2022 increased excitement around artificial intelligence (AI)...
exposome illustration

Fully Exposed: Understanding the Exposome Can Drive the Future of Health and Wellness

The field of exposomics is still in its early stages. Pioneering researchers are grappling with methods to marry multi-omic datasets, blood and urine mass spectrometry data, and even postal code and satellite data to gain insights into the highly complex interface between human biology and environmental exposures--and how it affects human health and wellness.
Michelle Werner

In Conversation with Michelle Werner

Inside Precision Medicine’s editor in chief, Damian Doherty, spoke to Werner, Alltrna's CEO, about her career, her motivation to lead this company, and what rare disease means to her on a personal level.

Trending on Inside Precision Medicine

Acute lymphoblastic leukemia ALL-L2 blood smear under light microscopy

Genetic Variant Identified Responsible for Higher Risk of ALL in Latinos

Research from investigators at the Keck School of Medicine of USC has identified a key genetic variant that contributes to the increased risk of developing acute lymphoblastic leukemia among children of Hispanic/Latino origin.
Model of Antibody Bevacizumab

Cancer Drug Part of New Combination Therapy Targeting TB

Researchers have devised a host-directed therapy (HDT) approach to targeting TB, which uses the anticancer drug bevacizumab in combination with losartan, to improve blood flow within granulomas and normalize the extracellular matrix (ECM).
Human blood cells, SEM

New Atlas of Rare Stem and Progenitor Cells Reveals New Cell Types

Researchers have developed a new atlas of rare hematopoietic stem and progenitor cells, those cells that trigger production of mature blood cells.

Daily News

Related Content

Inside Precision Medicine